Valneva may have won the chikungunya vaccine race with its world-first approval, but Bavarian Nordic’s option is the first to offer virus protection to adolescents 12 and older. More: Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine
read more
New data has shown that around a third of women do not attend screenings after being invited More: NHS England launches first-ever breast cancer screening campaign Source: News
read moreWhile Exelixis has abandoned a plan to seek an FDA approval for a combination of its Cabometyx and Bristol Myers’ Opdivo and Yervoy in kidney cancer, the biotech is hopeful that its next-gen tyrosine kinase inhibitor could have a place
read moreThe FDA has given a thumbs up to Sanofi’s Merilog as the first biosimilar substitute for Novo Nordisk’s NovoLog for patients with diabetes. It is delivered by a subcutaneous shot 5 to 10 minutes before mealtime to help patients manage
read moreICU Medical has voluntarily recalled two lots of potassium chloride intravenous bags, citing a labeling problem that could lead users to overdose on the IV solution. More: ICU Medical recalls potassium chloride IV bags over labeling snafu Source: fierce
read moreArgenx is urging patients to “Live Vyvidly.” The biotech put the message out in a direct-to-consumer TV ad that paints Vyvgart Hytrulo as a drug that can help people with chronic inflammatory demyelinating polyneuropathy live life to the fullest. More:
read more© 1994 - 2025 B.M. Pharmaceuticals